Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol (Q44985458)

8 December 2017

title

Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol (English)

1 reference

8 December 2017

1 reference

7

1 reference

8 December 2017

8

1 reference

8 December 2017

9

1 reference

8 December 2017

Herbert Kuster

5

0 references

author name string

Peter Rusert

1

1 reference

8 December 2017

Marek Fischer

2

1 reference

8 December 2017

Beda Joos

3

1 reference

8 December 2017

Christine Leemann

4

1 reference

8 December 2017

Markus Flepp

6

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

8 December 2017

number of pages

17

1 reference

inferred from page(s)

published in

Virology

1 reference

8 December 2017

volume

326

1 reference

8 December 2017

issue

1

1 reference

8 December 2017

page(s)

113-129

1 reference

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

8 December 2017

cites work

2 references

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

7 January 2021

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

7 January 2021

Expression and Characterization of CD4-IgG2, a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Plasma viremia in human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Is human immunodeficiency virus RNA load composed of neutralized immune complexes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

HIV-1 in placentas of untreated HIV-1-infected women in relation to viral transmission, infectious HIV-1 and RNA load in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Plasma viraemia as a marker of viral replication in HIV-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Inhibition of Plating of Human T Cell Leukemia Virus Type I and Syncytium-Inducing Types of Human Immunodeficiency Virus Type 1 by Polycations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Direct detection of infectious HIV-1 in blood using a centrifugation-indicator cell assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Centrifugal enhancement of human immunodeficiency virus type 1 infection and human cytomegalovirus gene expression in human primary monocyte/macrophages in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Complexation of retrovirus with cationic and anionic polymers increases the efficiency of gene transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Distribution of HIV type 1 (HIV-1) in blood components: detection and significance of high levels of HIV-1 associated with platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Recruitment of HIV and its receptors to dendritic cell-T cell junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Human immunodeficiency virus-specific CD8( ) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Modelling viral and immune system dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Modeling plasma virus concentration during primary HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

The supportive role of complement in HIV pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

HIV-1 attachment: another look.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Viral dynamics in human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Roles of substrate availability and infection of resting and activated CD4 T cells in transmission and acute simian immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

7 January 2021

Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

7 January 2021

Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

7 January 2021

Comparison of culture- and non-culture-based methods for quantification of viral load and resistance to antiretroviral drugs in patients given zidovudine monotherapy.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

7 January 2021

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

7 January 2021

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2004.05.022

7 January 2021

10.1016/J.VIROL.2004.05.022

Identifiers

DOI

1 reference

8 December 2017

1 reference